2026 NPPES data Plastic Surgery within the Head & Neck (Otolaryngology) Physician NPI 1306847215 M.D.
Verify on CMS →

UMANG KHETARPAL, M.D.

Plastic Surgery within the Head & Neck (Otolaryngology) Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
783
Medicare Part D claims · 227 beneficiaries · Plastic Surgery within the Head & Neck (Otolaryngology) Physician avg: 379
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$74.1
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

UMANG KHETARPAL, M.D. filed 783 Medicare Part D claims in 2023 as a Plastic Surgery within the Head & Neck (Otolaryngology) Physician in HOUSTON, Texas, prescribing 94% generic.

783
Part D claims, 2023
94%
generic prescribing
$74.1
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

UMANG KHETARPAL, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

783 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

UMANG KHETARPAL, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about UMANG KHETARPAL, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/02/2005

NPI 1306847215

Primary specialty

Plastic Surgery within the Head & Neck (Otolaryngology) Physician

Niche

608 US NPIs in this specialty

Medicare Part D claims

783 107% vs specialty avg

2023 prescription claims

Specialty avg: 379

Specialty distribution in Texas

How Plastic Surgery within the Head & Neck (Otolaryngology) Physician compares to other specialties among Texas providers

Texas providers

Plastic Surgery within the Head & Neck (Otolaryngology) Physician share within Texas

1. Plastic Surgery within the Head & Neck (Otolaryngology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Plastic Surgery within the Head & Neck (Otolaryngology) Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Plastic Surgery within the Head & Neck (Otolaryngology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Plastic Surgery within the Head & Neck (Otolaryngology) Physician ABMS/AOA estimate

Est. board-certified rate (Plastic Surgery within the Head & Neck (Otolaryngology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Plastic Surgery within the Head & Neck (Otolaryngology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

UMANG KHETARPAL, M.D. appears in the CMS NPPES registry as a Plastic Surgery within the Head & Neck (Otolaryngology) Physician provider holding M.D. credentials at 1800 W 26TH ST STE 100, HOUSTON, TX, 77008, with a listed phone of (832) 990-2700. NPI 1306847215 was issued on 08/02/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHETARPAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 783 prescription claims written by this provider, covering 227 Medicare beneficiaries and totaling roughly $30K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 4.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Plastic Surgery within the Head & Neck (Otolaryngology) Physician is a narrow specialty nationwide, with 608 enrolled providers across 48 states and an average of 379 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1800 W 26TH ST STE 100
HOUSTON, TX 77008

Provider Details

NPI 1306847215
Specialty Plastic Surgery within the Head & Neck (Otolaryngology) Physician
Credentials M.D.
Gender Male
NPI Issued 08/02/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for UMANG KHETARPAL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$74

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to UMANG KHETARPAL, M.D.. To verify UMANG KHETARPAL, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

UMANG KHETARPAL, M.D. — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 783 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

783
Total Claims
$30K
Total Drug Cost
227
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,013
Total Day Supply
22,541
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$11K
Generic Drug Cost
$19K
Opioid Claims
33 (4.2% rate)
Antibiotic Claims
156

Patient Demographics

Average Patient Age
71.6 years
Avg HCC Risk Score
1.32
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What UMANG KHETARPAL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Fluticasone Propionate
216
Prednisone
112
Ipratropium Bromide
84
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
67
Epinephrine
65
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
53
Azelastine Hcl
34
Famotidine
33
Acetaminophen-Codeine
Acetaminophen With Codeine
24
Omeprazole
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Plastic Surgery within the Head & Neck (Otolaryngology) Physician Overview

How UMANG KHETARPAL, M.D. fits within the Plastic Surgery within the Head & Neck (Otolaryngology) Physician landscape nationally.

608
Plastic Surgery within the Head & Neck (Otolaryngology) Physician Providers in US
48
States with Plastic Surgery within the Head & Neck (Otolaryngology) Physician
379
Avg Claims per Provider

UMANG KHETARPAL, M.D.'s 783 claims are above the specialty average of 379.

Nearby Plastic Surgery within the Head & Neck (Otolaryngology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as KHETARPAL.

Compare Plastic Surgery within the Head & Neck (Otolaryngology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is UMANG KHETARPAL, M.D.'s specialty?
UMANG KHETARPAL, M.D. specializes in Plastic Surgery within the Head & Neck (Otolaryngology) Physician and practices in HOUSTON, Texas. Credentials: M.D..
How much does UMANG KHETARPAL, M.D. prescribe under Medicare Part D?
In 2023, UMANG KHETARPAL, M.D. wrote 783 Medicare Part D claims totaling $30K in drug costs for 227 beneficiaries.
Where is UMANG KHETARPAL, M.D. located?
UMANG KHETARPAL, M.D. is located at 1800 W 26TH ST STE 100, HOUSTON, TX, 77008. Phone: (832) 990-2700.
What is UMANG KHETARPAL, M.D.'s NPI number?
UMANG KHETARPAL, M.D.'s National Provider Identifier (NPI) is 1306847215, issued on 08/02/2005.
Does UMANG KHETARPAL, M.D. prescribe more brand-name or generic drugs?
UMANG KHETARPAL, M.D.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $11K in brand drug costs.
Does UMANG KHETARPAL, M.D. prescribe opioids?
Yes, UMANG KHETARPAL, M.D. had 33 opioid claims in 2023 with an opioid prescribing rate of 4.2%.
How many Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers are there in the US?
There are 608 Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers across 48 states in the US. The average Plastic Surgery within the Head & Neck (Otolaryngology) Physician provider writes 379 Medicare Part D claims per year.
What drugs does UMANG KHETARPAL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, UMANG KHETARPAL, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Prednisone, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does UMANG KHETARPAL, M.D. accept Medicare?
UMANG KHETARPAL, M.D. appears in CMS Medicare data with 783 Part D claims and 227 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify UMANG KHETARPAL, M.D.'s credentials?
UMANG KHETARPAL, M.D.'s NPI is 1306847215 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology